Compare CNTX & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTX | MFM |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 223.2M |
| IPO Year | 2021 | N/A |
| Metric | CNTX | MFM |
|---|---|---|
| Price | $2.28 | $5.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 78.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | ★ 69.33 | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $184.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $4.94 |
| 52 Week High | $2.85 | $5.67 |
| Indicator | CNTX | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 57.83 |
| Support Level | $2.06 | $5.25 |
| Resistance Level | $2.58 | $5.60 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 39.80 | 44.74 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.